Sumagpit, Baby Boy .

HRN: 26-20-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2024
AMPICILLIN 500MG (VIAL)
11/13/2024
11/21/2024
INTRAVENOUS
85 Mg IVTT
Every 12 Hours
Neonatal Pneumonia
Waiting Final Action 
11/13/2024
CEFOTAXIME 500MG (VIAL)
11/13/2024
11/21/2024
INTRAVENOUS
43 Mg IVTT
Every 12 Hours
Neonatal Pneumonia
Waiting Final Action 
11/17/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
11/17/2024
11/23/2024
IV
20mg As LD Then 10mg
OD
Neonatal Sepsis
Waiting Final Action 
11/18/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/18/2024
11/24/2024
TOPICAL
1ml
TID
Swelling On IV Site
Waiting Final Action 
11/23/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/23/2024
11/29/2024
IV
170 Mg
Q8H
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: